AMPIO PHARMACEUTICALS INC (AMPE)

US03209T3077 - Common Stock

0.62  -0.09 (-12.91%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
9.52M20.38M20.57M15.83M18.58M
Research and Development
2.32M7.89M10.83M8.01M12.62M
Selling, General, and Administrative Expenses
7.08M11.47M8.65M6.65M5.95M
Operating Income
-9.52M-20.38M-20.57M-15.83M-18.58M
Interest Income/Expense
348.00K5.98M3.50M-530.00K4.95M
Other Income/Expense
594.00KN/AN/AN/AN/A
Non Recurring Items
-56.00K-1.94M0.00540.00KN/A
Income Before Taxes
-8.63M-16.34M-17.08M-15.89M-13.63M
Net Income
-8.63M-16.34M-17.08M-15.89M-13.63M
EBITDA
-9.40M-19.33M-19.48M-14.65M-17.31M
 
Per Share Data
EPS Diluted Total Ops
-10.66-21.78-25.87-27.39-30.97
Non GAAP EPS
N/AN/A-0.86N/AN/A
 
Statistics

All data in USD

Charts